Starling Oncology, Inc. Increase (Decrease) in Other Current Assets
Starling Oncology, Inc. (STLN) reported Increase (Decrease) in Other Current Assets of $0 for the 9-month period ending 2022-09-30, per its 10-Q filed 2022-11-09.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherCurrentAssets · last filed 2022-11-09
- Starling Oncology, Inc. increase (decrease) in other current assets for the quarter ending 2022-09-30 was $0.00, a 100.00% decline year-over-year.
- Starling Oncology, Inc. increase (decrease) in other current assets for the quarter ending 2022-06-30 was $0.00, a 100.00% decline year-over-year.
- Starling Oncology, Inc. increase (decrease) in other current assets for the quarter ending 2022-03-31 was $0.00, a 100.00% decline year-over-year.
- Starling Oncology, Inc. increase (decrease) in other current assets for the quarter ending 2021-09-30 was $3.01M.
| Period end | Increase (Decrease) in Other Current Assets 3 month | Increase (Decrease) in Other Current Assets 6 month | Increase (Decrease) in Other Current Assets 9 month |
|---|---|---|---|
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $0.00 derived: sum of 2 quarters · filed 2022-11-09 | $0.00 10-Q · filed 2022-11-09 |
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $0.00 10-Q · filed 2022-08-09 | |
| 2022-03-31 | $0.00 10-Q · filed 2022-05-10 | ||
| 2021-09-30 | $3.01M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $8.74M derived: sum of 2 quarters · filed 2022-11-09 | $9.09M 10-Q · filed 2022-11-09 |
| 2021-06-30 | $5.73M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $6.08M 10-Q · filed 2022-08-09 | |
| 2021-03-31 | $353.00K 10-Q · filed 2022-05-10 |